NNE — Filing of Resale Registration Statement
Jun 10, 2025, 12:00:00 AM UTC
Summary
Nano Nuclear Energy Inc. has filed a Resale Registration Statement with the SEC, following a private placement of 3,888,889 shares of its common stock. The shares were sold at a price of $27.00 per share, generating gross proceeds of approximately $105 million, which the company intends to use for research, marketing, working capital, and potential acquisitions. The registration statement must be effective within 30 or 60 days of filing, depending on SEC review. Nano Nuclear Energy is classified as an emerging growth company.
Company
NANO NUCLEAR ENERGY INC (NNE)NASDAQ — Industrials: Transportation Communications Electric Gas And Sanitary Service, Specialty Industrial Machinery: Electric Services
nanonuclearenergy.comSimilar Events
Effectiveness of Resale Registration Statement.
Xtant Medical Holdings, Inc. announced that the SEC is expected to declare its resale registration statement effective on June 15, 2025, pending no review. The statement is necessary for registering approximately 73.1 million shares of common stock that were sold to a group of investors, including Nantahala Capital Management, LLC, as part of a stock purchase agreement that closed on April 15, 2025. With Nantahala acquiring 49.1% of the outstanding shares, this transaction resulted in a change of control of the company, which may impact future governance and corporate strategies. The company must manage the potential market impact from a substantial number of shares becoming available for public resale.
Effective Registration StatementResale Registration Statement Filing Deadline
Applied Digital Corporation is approaching a deadline on June 9, 2025, for filing a resale registration statement with the U.S. Securities and Exchange Commission. This filing will cover common stock that can be issued upon conversion of its Series G Preferred Stock and certain warrants granted to AI Bridge Funding, LLC. The obligation to file arises from a Preferred Equity Purchase Agreement, emphasizing the financial commitments related to its equity activities, particularly amidst planned offerings targeted at $200 million to support growth initiatives. This registration is critical as it may facilitate liquidity for investors pertaining to the common shares associated with these convertible securities.
Regulatory filingResale Registration Statement Filing Deadline
Aethlon Medical, Inc. must file a resale registration statement by June 16, 2025, to register shares underlying Replacement Warrants. This filing follows their recent agreement that induces existing warrant holders to exercise their warrants early, issuing new unregistered stock purchase warrants. The company expects to gain gross proceeds of approximately $2.3 million from exercised warrants. The generated capital will be used for working capital and general corporate purposes. The New Warrants offer purchase rights at $0.3736 per share and have a term of 5.5 years, starting six months after issuance. Potential penalties await if the registration is not filed by the deadline, highlighting the importance of this filing for Aethlon Medical and its investors.
Registration Statement FilingInitial Registration Statement Filing with SEC
Sonim Technologies, Inc. filed an initial registration statement with the SEC to register the resale of 1,100,000 shares of common stock and warrants to purchase 550,000 additional shares. The filing follows subscription agreements entered into on May 12, 2025, totaling $1,375,000. The company intends to use the proceeds for working capital and general corporate purposes. The registration statement is expected to be filed by July 12, 2025, and the company has committed to use reasonable efforts to secure its effectiveness by November 12, 2025. The issuance was made under exemptions from registration requirements, and the agreement includes indemnification clauses for holders of the securities.
Initial Registration Statement Filing